Advertorial Sponsored by BYND CannaSoft

Sponsored on behalf of BYND Cannasoft: 
This under-the-radar NASDAQ company is now bringing AI technology to the massive wellness industry in a unique way.

What started as a medical cannabis company has evolved into so much more for BYND Cannasoft Enterprises Inc. (Nasdaq: BCAN), which now owns cutting-edge AI-based technology that is anticipated to disrupt the female wellness space!

Download Research Report

Learn More about BYND Cannasoft Enterprises Inc. by gaining access to the latest research report

    Thanks for subscribing!
    Check your email for a confirmation message.

    Check out this video from the Company’s NASDAQ ceremony below:

    The Beginning…

    Based in Israel, BYND Cannasoft Enterprises Inc. has a long background in marketing its proprietary CRM software, known as Benefit CRM to hundreds of clients with a monthly recurring revenue model.

    The company is aiming to help cannabis growers manage their day-to-day business activities and is developing big data software for cannabis.

    In 2022, BYND Cannasoft launched a beta test for managing farms with the CRM platform at Israel’s Weizmann Institute of Science. The Weizmann Institute of Science is one of the world’s leading multidisciplinary basic research institutions in the natural and exact sciences. It is located in Rehovot, Israel, south of Tel Aviv.

    The company has also received a license to engage in medical cannabis without direct contact with the substance from the Medical Cannabis Unit at the Ministry of Health of the State of Israel.  This license allows trading in medical cannabis products through an agreement with a licensed cannabis grower in the country. 

    The medical cannabis products market in Israel currently has about 150,000 users with an annual sales volume of about half a billion dollars. The company intends to capture hundreds of millions in market share!

    BYND Cannasoft Enterprises Inc. could be entering a phase of unprecedented growth as the CRM platform answers the needs of the medical cannabis industry.

    In addition to this already successful business, the company now sees tremendous growth potential with a patent-pending intellectual property that is the foundation of an innovative AI-based device!

    A Big Splash into the AI Boom….

    The rapid rise of artificial intelligence (AI) is reshaping the world. From Google and Amazon to Apple and Microsoft, every major tech company is dedicating resources to breakthroughs in this growing technology.

    A surge in Wall Street's interest in AI has intensified in recent years with the technology being mentioned on many earnings calls.

    AI is disrupting many industries, including health and wellness, where there is a growing need for specialized tools and solutions. Answering this demand is BYND Cannasoft Enterprises Inc.

    As the AI boom intensifies, BYND Cannasoft Enterprises Inc. (Nasdaq: BCAN) is bridging the marvels of AI technology with the growing women’s

    Health Market.

    A Pivotal Acquisition…. 

    In September of 2022, BYND Cannasoft completed its acquisition of Israeli-based Zigi Carmel Initiatives & Investments Ltd.

    Through the acquisition, BYND Cannasoft now owns the patent-pending intellectual property for the EZ-G device and has been planning its launch for the wellness market.

    The EZ-G device is a therapeutic device that uses proprietary software to regulate the flow of low concentrations of CBD oil, hemp seed oil, and other natural oils into the soft tissues of the female reproductive system to potentially treat a wide variety of women's health issues.

    Designed with the modern woman in mind, the EZ-G Device is equipped with cutting-edge technology that offers a truly unique and personalized experience.

    The EZ-G Device

    Based on much research, CBD oil can potentially provide relief to certain issues in the female reproductive system. The EZ-G device incorporates technological advancements as a pleasure product, providing a more realistic experience. Equipped with sensors such as a pressure sensor, temperature sensor, conductivity sensor, and heart rate sensor, the EZ-G device prototype aims to identify specific factors that enhance users' pleasure.

    Sense: The device features a heart rate sensor, pressure sensor, and EC sensor that work together to learn about your body and your preferences. With this information, the company’s ML - AI algorithm creates a tailored experience that will leave you feeling satisfied every time. 

    Abilities: In addition, the device has a training program for the pelvic floor muscles, which can help improve bladder control and enhance pleasure. It also includes treatments for pain and discomfort, which can be a common issue for many women. 

    Lubrication PH balanced capsules: To make the experience even more enjoyable, the company has added lube base CBD capsules ( CBD use will be contingent upon obtaining necessary legal approvals and complying with relevant regulations.), or natural ingredient lube water PH balance, to reduce friction and increase pleasure.

    According to research conducted across the globe, treatment with low-concentration CBD oils can relieve candida, dryness, scars, and many other female health issues.  Numerous studies have shown CBD interacts with the endocannabinoid system, a master regulatory system with receptors all around the body. 

    By activating these receptors, CBD can have health benefits that help make intimacy more approachable and pleasurable by reducing stress, enhancing one’s mood, promoting body comfort, and treating vaginal issues.

    How does AI come into play?

    With artificial intelligence (AI), the device transmits and receives data from these sensors, capturing information about the conditions of the user's sensitive pleasure organs.

    A Bluetooth component…

    The EZ-G prototype is designed with a Bluetooth component, enabling users to control the adult device via an app installed on a smartphone or other portable device. 

    This app allows for the collection of user information on preferences, generating custom programs tailored to individual needs. The data collected from the sensors is securely uploaded to the cloud, where it is combined with preferences from other users. Factors such as the actual duration of operation of the adult device, lubrication level, and ideal vibration intensity are analyzed to optimize the device's performance and enhance satisfaction.

    Key milestones in the development of the EZ-G Device:

    1. In line with BYND Cannasoft's customer-centric approach, the Company plans to engage a focus group to perform rigorous testing and evaluation of the EZ-G Device in Q1 2024. This process will provide valuable insights and user feedback, helping to refine the product to exceed customer expectations. 
    2. Finalizing the EZ-G Device Prototype and Software by the End of Q4 2023, upon insights gained from the focus group, BYND Cannasoft intends to build on its recent successful completion of the laboratory testing phase by fine-tuning the EZ-G Device's prototype and software. The Company is dedicated to refining user experience and functionality to introduce a superior product. 
    3. Going to Market with the EZ-G Device in Q2 2024: With a meticulously developed and thoroughly tested product, BYND Cannasoft’s management believes the Company is on track for a market launch of the EZ-G Device in the first quarter of 2024. The Company anticipates that the product will set new industry benchmarks.

    The Neglected Half of The Population is a Big Market…

    Wellness and healthcare are male-focused spaces but that doesn't do much to serve the female half of the population. Medicine and wellness have for very long been a male-dominated science and profession. This has led to women's health issues being somewhat neglected. 

    Even today, “Approximately 1% of healthcare research is invested in female-specific conditions beyond oncology”, and “Women’s Health conditions outside of oncology comprise less than 2% of the current healthcare pipeline”. source

    In addition, women's bodies are somewhat more complex than men's, with different hormonal patterns, organs, etc. What works for men might not always work for women!

    Women have become an absolute main driver of wellness. With rising awareness of the importance of health and improvement, the female wellness sector has been growing rapidly and the landscape is changing.

    Taboos are being destigmatized. More female consumers understand that they don't have to be kept in a "tiny box." Previously stigmatized topics in women's health are going mainstream which is fueling the growth of the market. The boundaries of conversation are being pushed in various platforms and advertising with no signs of slowing down.

    There is no one-size-fits-all solution. Wellness can be for all women, but it is also unique. Consumers of different ages, backgrounds, and body types are looking for product offerings that work for them. This is increasing the need for innovative solutions. Millennial females are growing into midlife and represent a massive market. They want better products and more open conversation.

    Data from global market research consultancy Acumen Research and Consulting showed that the women's global healthcare and wellness management market reached $25.3 billion in 2021, with the sector expected to grow to $97.3 billion by 2030. This means the compound annual growth rate (CAGR) between 2022 and 2030 is expected to be over 16 percent!

    The sector has also come to the attention of bigger corporations where acquisitions or licensing deals look promising.

    5 Reasons to Have BYND Cannasoft Enterprises Inc. on Your Radar:

    1. The global artificial intelligence (AI) market size was valued at USD 454.12 billion in 2022 and is expected to hit around USD 2,575.16 billion by 2032, progressing with a compound annual growth rate (CAGR) of 19% from 2023 to 2032. Savvy investors are on the hunt for promising young companies in the AI space and this company is standing out.
    2. As consumers recognize the benefits of cannabis, worldwide legal-cannabis sales are expected to rise 15%, to $37 billion in 2023. The company is committed to driving positive change in the medical cannabis landscape through meaningful research and collaboration with esteemed institutions.
    3. The global women's health market size was valued at USD 41.35 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 5.4% from 2023 to 2030. With a game-changing device aimed at helping women, the company could soon generate spectacular exposure as it goes after a massive underserved market.
    4. To protect its innovations and maintain its competitive edge, BYND Cannasoft subsidiary Zigi Carmel Initiatives & Investments LTD has filed multiple patents related to its AI technology to protect the IP owned by the company. A patent application for the company’s AI-based EZ-G device has recently been filed with the World Intellectual Property Office, also known as WIPO. This is a significant milestone!
    5. The company recently celebrated the successful completion of the laboratory testing phase of its groundbreaking project, the EZ-G device. As mentioned in a press release dated July 10, 2023, the laboratory testing phase aimed to optimize the various sensors in this innovative device. Completing this project phase within a remarkably efficient timeline showcases the company's dedication to innovation and technological prowess.

    "Our journey at BYND Cannasoft is shaping up to be nothing short of remarkable. We are driven by a passion for innovation and a commitment to positively impacting the women's health and medical cannabis space. Our latest achievements, from securing key patents to completing the initial testing on our groundbreaking EZ-G device, have only strengthened our resolve to continue pushing the boundaries of what is possible in this industry."

    Yftah Ben Yaackov, CEO and Director of BYND

    In Summary…

    The technology behind BYND Cannasoft’s EZ-G device showcases the company’s commitment to shaping the future of machine learning. The product could have a potential impact on women's health worldwide.

    BYND Cannasoft has spent nearly two decades establishing its successful CRM business and is now prepared to bring its new division into the spotlight. 

    The company knows the demand there is for CBD and is recognizing a niche market that is underpenetrated and needs solutions. The female wellness landscape has transitioned into a mainstream topic where the EZ-G device could capture a massive market share. 

    A product launch aimed at Q2 2024 could mean major buzz for the company well before then as anticipation grows!

    BYND Cannasoft Enterprises Inc. (Nasdaq: BCAN)’s story is only truly beginning now after its strategic acquisition of innovative AI technology. As the AI race continues, this underfollowed company is one to keep your eyes closely on!


    Learn More about BYND Cannasoft Enterprises Inc.  by gaining access to the latest research report

    Download Report




    SCD Media LLC (d/b/a “Smallcaps Daily”), hereinafter referred to as “Smallcaps Daily,” and their affiliates and control persons (the “Publisher”) are in the business of publishing favorable information and/or advertisements (the “Information”) about the securities of publicly traded companies (each an “Issuer” or collectively the “Issuers”) in exchange for compensation (the “Campaigns”). Persons receiving the Information are referred to as the “Recipients.” The person or entity paying the Publisher for the Campaign is referred to herein as the “Paying Party”. The Paying Party may be an Issuer, an affiliated or non-affiliate shareholder of an Issuer, or another person hired by the Issuer or an affiliate or non-affiliate shareholder of the Issuer. The nature and amount of compensation paid to the Publisher for the Campaign and creating and/or publishing the Information about each Issuer is set forth below under the heading captioned, “Compensation”.

    This website provides information about the stock market and other investments. This website does not provide investment advice and should not be used as a replacement for investment advice from a qualified professional. This website is for informational purposes only. The Author of this website is not a registered investment advisor and does not offer investment advice. You, the reader, bear responsibility for your own investment decisions and should seek the advice of a qualified securities professional before making any investment.

    Nothing on this website should be considered personalized financial advice. Any investments recommended herein should be made only after consulting with your personal investment advisor and only after performing your own research and due diligence, including reviewing the prospectus or financial statements of the issuer of any security.


    Smallcaps Daily, its managers, its employees, affiliates, and assigns (collectively the "Publisher") do not make any guarantee or warranty about the advice provided on this website or what is otherwise advertised above.


    Release of Liability: through use of this website, viewing or using you agree to hold Smallcaps Daily, its operators, owners, and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Smallcaps Daily encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the company profiled or is available from public sources and Smallcaps Daily makes no representations, warranties, or guarantees as to the accuracy or completeness of the disclosure by the profiled company. None of the materials or advertisements herein constitute offers or solicitations to purchase or sell securities of the companies profiled herein and any decision to invest in any such company or other financial decisions should not be made based upon the information provided herein. Instead, Smallcaps Daily strongly urges you to conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. Smallcaps Daily’s full disclosure is to be read and fully understood before using Smallcaps Daily's website, or joining Smallcaps Daily's email or text list. From time to time, Smallcaps Daily will disseminate information about a company via website, email, sms, and other points of media. By viewing Smallcaps Daily's website and/or reading Smallcaps Daily's email or text newsletter you are agreeing to this ----> https://Smallcaps All potential percentage gains discussed in any communications are based on calculations from the low to the high of the day. We are engaged in the business of marketing and advertising companies for monetary compensation.  

    If you have questions or concerns about a product you’ve seen in one of our emails, emails, text newsletters or SMS, we encourage you to reach out to that company directly.

    Disclaimer – Always do your own research and consult with a licensed investment professional before investing. This communication is never to be used as the basis of making investment decisions and is for entertainment purposes only. At most, this communication should serve only as a starting point to do your own research and consult with a licensed professional regarding the companies profiled and discussed. Conduct your own research. This newsletter is a paid advertisement, not a recommendation nor an offer to buy or sell securities. This newsletter is owned, operated, and edited by the owner of Smallcaps Daily. Any wording found in this e-mail or disclaimer referencing to “I” or “we” or “our” refers to Smallcaps Daily. Our business model is to be financially compensated to market and promote small public companies. By reading our newsletter and our website you agree to the terms of our disclaimer, which are subject to change at any time. We are not registered or licensed in any jurisdiction whatsoever to provide investing advice or anything of an advisory or consultancy nature and are therefore unqualified to give investment recommendations. Companies with low prices per share are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service, you agree not to hold our site, its editors, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters or on our website. We do not advise any reader to take any specific action. Losses can be larger than expected if the company experiences any problems with liquidity or wide spreads. Our website and newsletter are for entertainment purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter and on our website may be based on end-of-day or intraday data. This publication and its owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. If we own any shares, we will list the information relevant to the stock and the number of shares here.


    In compliance with section 17(b) of the Securities Act we are disclosing that we have been compensated a fee pursuant to an agreement between Smallcaps Daily and IA Media LLC (d/b/a/ “IA Media”) hereinafter referred to as IA Media. Please see IA Media’s disclosure page here.  Small Caps Daily was hired by IA Media for a period beginning September 2023 and ending October 2023 to publicly disseminate information about BYND Cannasoft Enterprises Inc. via website, email, and SMS. We were paid up to twenty-five thousand usd via ACH. Readers are advised to review SEC periodic reports: forms 10Q 10K, form 8K, insider reports, forms 3, 4, 5 schedule 13d. Smallcaps Daily is compliant with the CAN-SPAM Act of 2003. Smallcaps Daily does not offer investment advice or analysis, and Smallcaps Daily further urges you to consult your own independent tax, business, financial, and investment advisors. investing in micro-cap, small-cap, and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or impaired due to the speculative nature of the companies profiled. The private securities litigation reform act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events, or performance are not statements of historical fact but may be forward-looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward-looking statements in this action may be identified through the use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quotes; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results in preparing this publication. Smallcaps Daily has relied upon information supplied by its clients, as well as its clients’ publicly available information and press releases which it believes to be reliable; however, such reliability can not be guaranteed. Investors should not rely on the information contained on this website. Rather, investors should use the information contained in this website as a starting point for doing additional independent research on the featured companies. The advertisements in this website are believed to be reliable, however, Smallcaps Daily and its owners, affiliates, subsidiaries, officers, directors, representatives, and agents disclaim any liability as to the completeness or accuracy of the information contained in any advertisement and for any omissions of material facts from such advertisement. Smallcaps Daily is not responsible for any claims made by the companies advertised herein, nor is Smallcaps Daily responsible for any other promotional firm, its program, or its structure. Smallcaps Daily is not affiliated with any exchange, electronic quotation system, the Securities Exchange Commission, or FINRA.

      Thanks for subscribing!
      Check your email for a confirmation message.